Medication* | Treatment group; no. of patients† | |
---|---|---|
Levomepromazine (LMP) (n = 19) | Chlorpromazine (CPZ) (n = 19) | |
Neuroleptic dose ≥ 1000 mg CPZ equivalents/d | 19 | 18‡ |
Duration on 1000 mg CPZ equivalents/d | ||
≥ 12 wk | 18 | 16 |
< 12 wk | 1 | 3 |
Mean dose in CPZ equivalents/d at baseline, (SD) [and range], mg | 1611 (879) [1000–3900] | 1872 (1333) [800–6250]‡ |
Duration medication was unchanged | ||
≥ 12 wk | 5 | 3 |
4 – < 12 wk | 10 | 13 |
< 4 wk | 4 | 3 |
Psychotropic medications limited to neuroleptics, anticholinergics and prn chloral hydrate | ||
≥ 12 wk | 10 | 5 |
4 – < 12 wk | 7 | 13 |
< 4 wk | 2 | 1 |